REVVITY, INC Capital Expenditure, Discontinued Operations
REVVITY, INC (RVTY) reported Capital Expenditure, Discontinued Operations of $1.30 million for the 12-month period ending 2017-01-01, per its 10-K filed 2017-02-28.
Discontinued › Notes › Discontinued Operations and Disposal Groups
us-gaap:CapitalExpenditureDiscontinuedOperations · last filed 2017-02-28
- REVVITY, INC capital expenditure, discontinued operations for fiscal 2017 was $1.30M, a 7.92% decline from fiscal 2016.
- REVVITY, INC capital expenditure, discontinued operations for fiscal 2016 was $1.41M, a 33.71% decline from fiscal 2014.
- REVVITY, INC capital expenditure, discontinued operations for fiscal 2014 was $2.13M.
| Period end | Capital Expenditure, Discontinued Operations 12 month |
|---|---|
| 2017-01-01 | $1.30M 10-K · filed 2017-02-28 |
| 2016-01-03 | $1.41M 10-K · filed 2017-02-28 |
| 2014-12-28 | $2.13M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |